OAC
NVAX icon

OMERS Administration Corp’s Novavax NVAX Stock Holding History

OMERS Administration Corp’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-199,100
Closed -$1.73M – 1252
2025
Q3 		$1.73M Hold
199,100
– – 0.01% 451
2025
Q2 		$1.25M Hold
199,100
– – 0.01% 474
2025
Q1 		$1.28M Buy
+199,100
New +$1.65M 0.01% 508

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OMERS Administration Corp's NVAX Position: Q4 2025 in Review

OMERS Administration Corp sold out of Novavax (NVAX) in Q4 2025, closing a stake of 199,100 shares — an estimated $1.73M sold.

OMERS Administration Corp first reported a position in NVAX in Q1 2025 and held it in 3 quarters. The position peaked at $1.73M in Q3 2025. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • OMERS Administration Corp reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 199,100 Novavax shares in Q4 2025, an estimated $1.73M.
  • OMERS Administration Corp first reported a position in Novavax in Q1 2025 and held it in 3 quarters.
  • OMERS Administration Corp's Novavax position peaked at $1.73M in Q3 2025.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.